Jessica Heck, PhD

Graduation: 05/2011
Advisor: Keely, Patricia
Current Position: Acute Care Clinical Pharmacist
Denver VA Medical Center (ECHCS)
Denver, CO
Research Interest: Breast cancer biology, cell signaling
Email: heck (dot) n (dot) jessica (at) gmail (dot) com


Alumni News

  • In addition to receiving her PhD from the MCP program, Jessica also received her PharmD from the UW-Madison School of Pharmacy. She completed her residency in Pharmacy practice at the Denver VA Medical Center and has accepted a permanent position there. She maintains strong ties to the Keely lab with a continued interest in breast cancer biology and has expanded her interests to include clinical research and patient outcomes.


  • Fallon MJ, Heck JN (2014). Fatal Stevens-Johnson syndrome/ toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy. J Oncol Pharm Pract. 0(0):1-5.  PMID: 25005569
  • Heck JN, Ponik SM, Garcia-Mendoza MG, Pehlke CA, Inman DR, Eliceiri KW, and PJ Keely (2012). Microtubules regulate GEF-H1 in response to extracellular matrix stiffness. Mol Biol Cell. 23:2583-2592. PMID: 3386221
  • Schramp M, Thapa N, Heck JN, and RA Anderson (2011). PIPKIgamma regulates beta-catenin transcriptional activity downstream of growth factor receptor signaling. Cancer Res. 71:1282-91. PMCID: PMC3066690
  • Heck JN, Mellman DL, Ling K, Sun Y, Wagoner MP, Schill NJ, and RA Anderson (2007). A conspicuous connection: structure defines function for the phosphatidylinositol phosphate kinase family. Crit Rev Biochem Mol Biol. 42:15-39. PMID: 17364683